v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue $ 59
Cost of revenue 54
Gross profit 5
Operating expenses:        
Research and development 492 955 1,523 3,523
Selling, general and administrative 2,941 2,160 10,926 8,634
Total operating expenses 3,433 3,115 12,449 12,157
Loss from operations (3,433) (3,115) (12,444) (12,157)
Other income (expense):        
Interest expense (2,445) (1) (6,970) (6)
Loss on extinguishment of warrant liability (504)
Loss on extinguishment of debt (2,345)
Gain on issuance of convertible notes 64
Change in fair value of warrants 2,688 10,424
Change in fair value of notes (40) (7,040)
Change in fair value of derivative liability 401 401
Other expense (30) (1,264)
Total other income (expense) 574 (1) (7,234) (6)
Loss before income taxes (2,859) (3,116) (19,678) (12,163)
Income tax expense
Net loss (2,859) (3,116) (19,678) (12,163)
Deemed dividend on Series D preferred stock (6)
Net loss attributable to common stockholders $ (3,142) $ (3,139) $ (20,154) $ (12,186)
Net loss per share attributable to common stockholders (in Dollars per share) $ (0.94) $ (11.76) $ (12.96) $ (48.58)
Weighted average shares outstanding, basic and diluted: (in Shares) 3,349,195 266,872 1,554,554 250,832
Series A Preferred Stock        
Other income (expense):        
Cumulative dividends $ (5) $ (14)
Series B Preferred Stock        
Other income (expense):        
Cumulative dividends (29) (78)
Series C Preferred Stock        
Other income (expense):        
Cumulative dividends (10) (20)
Series D Preferred Stock        
Other income (expense):        
Cumulative dividends (23) (53) (23)
Series F Preferred Stock        
Other income (expense):        
Cumulative dividends (144) (190)
Series F-1 Preferred Stock        
Other income (expense):        
Cumulative dividends (51) (71)
Series F-2 Preferred Stock        
Other income (expense):        
Cumulative dividends $ (44) $ (44)

Source